<DOC>
	<DOCNO>NCT03040713</DOCNO>
	<brief_summary>This study design assess usefulness 18F-AV-1451 Positron Emission Tomography image subject diagnose Frontotemporal Dementia .</brief_summary>
	<brief_title>Flortaucipir PET Imaging Subjects With FTD</brief_title>
	<detailed_description />
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Frontotemporal Dementia</mesh_term>
	<mesh_term>Aphasia , Primary Progressive</mesh_term>
	<mesh_term>Pick Disease Brain</mesh_term>
	<criteria>Have provide inform consent legally authorize ( LAR ) provide consent study procedure Have volumetric brain MRI obtain site 's companion protocol within one year enrollment Can tolerate PET scan procedure Have clinically significant cardiac , hepatic , renal , pulmonary , metabolic , endocrine disturbance pose potential safety risk Have history risk factor Torsades de Pointes ( TdP ) take medication know cause QT prolongation Have history drug alcohol dependence within last year Are females childbearing potential surgically sterile , refrain sexual activity , use reliable contraception Have history relevant severe drug allergy hypersensitivity Have receive investigational medication FDA IND protocol within 30 day plan image session Have receive radiopharmaceutical imaging/therapy within 24 hour image session Possess PET scan evidence amyloid deposition Determined investigator unsuitable type study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>